Fig. 5From: Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapyLandscape of potentially clinically actionable variants in plasma of LUAD. a Landscape of non-silent mutations of common reporter genes and three important pathway genes during chemotherapy. The y-axis represented the gene, whereas x-axis on behalf of samples. Different color showed different mutant type of non-silent mutations. b Plasma VAFs of key pathways during platinum-based chemotherapyBack to article page